Koers Tongling Jieya Biologic Technology Co., Ltd.
Aandelen
301108
CNE1000054S9
Persoonlijke Producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
26,88 CNY | -0,15% | +4,96% | -22,18% |
Omzet 2024 * | 720 mln. 99,37 mln. 92,92 mln. | Omzet 2025 * | 825 mln. 114 mln. 106 mln. | Marktkapitalisatie | 2,18 mld. 301 mln. 282 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 134 mln. 18,49 mln. 17,29 mln. | Nettowinst (verlies) 2025 * | 157 mln. 21,67 mln. 20,26 mln. | EV/omzet 2024 * | 3,03 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 2,65 x |
K/w-verhouding 2024 * |
16,2
x | K/w-verhouding 2025 * |
-
| Werknemers | 620 |
Dividendrendement 2024 * |
1,56% | Dividendrendement 2025 * |
1,82% | Vrij verhandelbaar | 28,37% |
1 dag | -0,15% | ||
1 week | +4,96% | ||
Lopende maand | -4,61% | ||
1 maand | -4,48% | ||
3 maanden | -11,72% | ||
6 maanden | -19,42% | ||
Lopend jaar | -22,18% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ying Chuan Cai
CEO | Chief Executive Officer | 54 | 31-08-99 |
Yun Feng Lu
CHM | Chairman | 41 | 01-08-18 |
Xian Guo Yuan
ADM | Chief Administrative Officer | 54 | 01-04-04 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Yun Feng Lu
CHM | Chairman | 41 | 01-08-18 |
Ying Chuan Cai
CEO | Chief Executive Officer | 54 | 31-08-99 |
Yan Feng
BRD | Director/Board Member | 50 | 01-08-99 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.09% | 12 M€ | -16,71% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 26,88 | -0,15% | 231 700 |
25-04-24 | 26,92 | +2,32% | 407 500 |
24-04-24 | 26,31 | +0,04% | 265 100 |
23-04-24 | 26,3 | +0,38% | 277 400 |
22-04-24 | 26,2 | +2,26% | 383 068 |
slotkoers Shenzhen S.E., 26 april 2024
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-22,18% | 302 mln. | |
-9,06% | 17,6 mld. | |
-9,81% | 3,8 mld. | |
+3,08% | 3,6 mld. | |
-3,52% | 2,43 mld. | |
-13,60% | 1,55 mld. | |
+40,30% | 1,22 mld. | |
+13,83% | 939 mln. | |
+24,39% | 797 mln. | |
+25,47% | 432 mln. |